TB control study for high-risk groups in Guangxi
Part of Infections clinical trials.
This study tests new ways to control the spread of tuberculosis (TB) in high-risk areas of Guangxi, China. It focuses on older adults and people with conditions that make them more likely to get TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- OR you are between 15 and 64 and have one of these: history of TB treatment, close contact with a TB patient in the last 3 years, diabetes, HIV positive, or worked as a miner
- You live in a high-prevalence area for TB in Guangxi, China
- You agree to sign a consent form
- You are not refusing to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common tuberculosis is in pregnant and new mothers. It aims to improve TB detection and care for women in Guinea-Bissau.
This study tests a community-based approach to improve tuberculosis (TB) monitoring and screening for immigrants who recently arrived from specific African and Asian countries. It aims to make TB checkups easier to access and understand.
This study looks at how to best manage latent tuberculosis (TB) infection using a test that finds people at risk. It aims to help doctors and patients make better decisions together.
This trial is testing a new way to find and treat tuberculosis (TB) in communities in Ethiopia. It aims to help people of any age who live in certain areas get better care.
This study screens people for tuberculosis (TB), a serious lung infection, using new testing methods. Researchers want to find TB cases early so people can get treatment before the disease becomes severe.
This trial is screening people in Henan, China for chronic lung diseases like COPD and tuberculosis (TB). It uses a CT scan to check your lungs and aims to find these conditions early.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.